| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |